Ipsen

The Director will provide medical leadership in the design, implementation, and interpretation of clinical development programs for rare liver diseases. They will serve as a medical monitor for clinical trials while ensuring compliance with global regulatory requirements and patient safety standards.

Lead and deliver risk-based GxP audits across internal and external partners while managing audit planning, execution, and reporting. Act as a subject matter expert to support regulatory inspections and provide coaching to peer auditors.

The Pediatric Rare Disease Medical Science Liaison will act as a liaison with thought leaders to discuss research and medical information, facilitating clinical trial efforts. This role involves engaging in scientific exchange and developing relationships with key stakeholders in the assigned territory.